Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Karrison

Showing results (111-120 of 155) with videos related to

Pageof 16
Sort By:
Gastrointestinal Endoscopy|February 10, 2019
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's diseaseJacob E Ollech, Maya Aharoni-Golan, Roni Weisshof, et al.
Clinical Pharmacology and Therapeutics|August 22, 2019
The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative CareTien M Truong, Jeffrey Apfelbaum, Sajid Shahul, et al.
British Journal of Haematology|April 19, 2017
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCLNatalie Galanina, Sonali M Smith, Chuanhong Liao, et al.
JAMA Oncology|July 21, 2022
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted StudyBenjamin A Derman, Ankit Kansagra, Jeffrey Zonder, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
The human BCL6 transgene promotes the development of lymphomas in the mouseBeverly W Baron, John Anastasi, Anthony Montag, et al.
Blood Advances|September 9, 2024
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosisChenyu Lin, Anand A Patel, Dezheng Huo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2012
Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009)Rima McLeod, Kenneth M Boyer, Daniel Lee, et al.
Investigational New Drugs|December 9, 2014
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasiaOlatoyosi Odenike, Anna Halpern, Lucy A Godley, et al.
Journal of Neurosurgery. Pediatrics|September 7, 2019
Outcomes of hydrocephalus secondary to congenital toxoplasmosisDavid McLone, David Frim, Richard Penn, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 12, 2023
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomyTareq Kass-Hout, Rami Z Morsi, Sonam Thind, et al.
Pageof 16

Showing results (111-120 of 155) with videos related to

Sort By:
Pageof 16
Gastrointestinal Endoscopy|February 10, 2019
Differential risk of disease progression between isolated anastomotic ulcers and mild ileal recurrence after ileocolonic resection in patients with Crohn's diseaseJacob E Ollech, Maya Aharoni-Golan, Roni Weisshof, et al.
Clinical Pharmacology and Therapeutics|August 22, 2019
The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative CareTien M Truong, Jeffrey Apfelbaum, Sajid Shahul, et al.
British Journal of Haematology|April 19, 2017
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCLNatalie Galanina, Sonali M Smith, Chuanhong Liao, et al.
JAMA Oncology|July 21, 2022
Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted StudyBenjamin A Derman, Ankit Kansagra, Jeffrey Zonder, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2004
The human BCL6 transgene promotes the development of lymphomas in the mouseBeverly W Baron, John Anastasi, Anthony Montag, et al.
Blood Advances|September 9, 2024
A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosisChenyu Lin, Anand A Patel, Dezheng Huo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2012
Prematurity and severity are associated with Toxoplasma gondii alleles (NCCCTS, 1981-2009)Rima McLeod, Kenneth M Boyer, Daniel Lee, et al.
Investigational New Drugs|December 9, 2014
A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasiaOlatoyosi Odenike, Anna Halpern, Lucy A Godley, et al.
Journal of Neurosurgery. Pediatrics|September 7, 2019
Outcomes of hydrocephalus secondary to congenital toxoplasmosisDavid McLone, David Frim, Richard Penn, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|July 12, 2023
Underlying intracranial atherosclerotic disease is associated with worse outcomes in acute large vessel occlusion undergoing endovascular thrombectomyTareq Kass-Hout, Rami Z Morsi, Sonam Thind, et al.
Pageof 16